More than 50 major insurers have pledged to streamline prior authorization starting in 2026, but providers remain cautiously optimistic and skeptical that the changes will truly reduce burden or ...

Deloitte’s 2026 Healthcare Outlook shows that while more than two-thirds of U.S. healthcare leaders expect to outperform competitors, rising policy uncertainty is pushing greater focus on digital care ...

A coalition of major pharmacy organizations urged Congressional leaders to enact long-stalled PBM reforms to curb ...

Texas Attorney General Ken Paxton sued Epic, alleging the company monopolizes the EHR market and restricts access to medical ...

Recent changes to ACIP leadership and vaccine guidance have raised concerns that longstanding immunization protections are ...

The Senate’s rejection of two ACA-focused healthcare bills widened partisan divides and sparked warnings from advocacy groups ...

CMS has been trying to scale value-based care for decades with mixed results — but the agency’s newly announced ACCESS model could represent a more meaningful step toward aligning payment with ...

As healthcare costs rise, prescription drugs can be one of the costliest aspects of the healthcare experience. In an interview, RxSaveCard CEO and Founder Chris Crawford talked about his new business ...

Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus Therapeutics, a company whose two commercialized products each offer ...

Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can ...

Trust in the U.S. healthcare system is eroding — but this decline isn’t happening evenly across the system, one leader pointed out. People largely trust individual clinicians, but they tend to ...

With Measurement Year (MY) 2024 complete, a new HEDIS season is now underway. The introduction of new measures, ongoing revisions to current measures, and regulatory updates create an ongoing need for ...